JPS5665829A - Antitumor agent - Google Patents
Antitumor agentInfo
- Publication number
- JPS5665829A JPS5665829A JP14215379A JP14215379A JPS5665829A JP S5665829 A JPS5665829 A JP S5665829A JP 14215379 A JP14215379 A JP 14215379A JP 14215379 A JP14215379 A JP 14215379A JP S5665829 A JPS5665829 A JP S5665829A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antitumor
- purity
- tumor
- purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 5
- 230000000259 anti-tumor effect Effects 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 230000000340 anti-metabolite Effects 0.000 abstract 2
- 229940100197 antimetabolite Drugs 0.000 abstract 2
- 239000002256 antimetabolite Substances 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 abstract 1
- 229960005508 8-azaguanine Drugs 0.000 abstract 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 abstract 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 208000007093 Leukemia L1210 Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 208000006268 Sarcoma 180 Diseases 0.000 abstract 1
- 238000001042 affinity chromatography Methods 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960000684 cytarabine Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960002949 fluorouracil Drugs 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14215379A JPS5665829A (en) | 1979-11-02 | 1979-11-02 | Antitumor agent |
| US06/103,474 US4315851A (en) | 1978-12-29 | 1979-12-14 | Pharmaceutical composition having antitumor activity |
| SE7910483A SE7910483L (sv) | 1978-12-29 | 1979-12-19 | Farmaceutisk komposition med tumorhemmande effekt |
| PH23447A PH16902A (en) | 1978-12-29 | 1979-12-20 | Pharmaceutical composition having anti-tumor activity |
| GB7944494A GB2038836B (en) | 1978-12-29 | 1979-12-28 | Antitumour substance |
| FR797932054A FR2445149B1 (fr) | 1978-12-29 | 1979-12-28 | Composition pharmaceutique ayant une activite antitumorale |
| CH11501/79A CH655010A5 (de) | 1978-12-29 | 1979-12-28 | Pharmazeutischer wirkstoff mit antitumoraktivitaet. |
| DE2952690A DE2952690C2 (de) | 1978-12-29 | 1979-12-29 | Antitumorsubstanz, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel |
| IT28464/79A IT1127324B (it) | 1978-12-29 | 1979-12-31 | Composizione farmaceutica avente attivita' antitumorale |
| US06/321,486 US4401592A (en) | 1978-12-29 | 1981-11-16 | Pharmaceutical composition having antitumor activity |
| SE8406510A SE8406510D0 (sv) | 1978-12-29 | 1984-12-20 | Farmaceutisk komposition med tumorhemmande effekt |
| SE8406511A SE8406511D0 (sv) | 1978-12-29 | 1984-12-20 | Farmaceutisk komposition med tumorhemmande effekt |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14215379A JPS5665829A (en) | 1979-11-02 | 1979-11-02 | Antitumor agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5665829A true JPS5665829A (en) | 1981-06-03 |
| JPS6256137B2 JPS6256137B2 (enrdf_load_stackoverflow) | 1987-11-24 |
Family
ID=15308586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14215379A Granted JPS5665829A (en) | 1978-12-29 | 1979-11-02 | Antitumor agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5665829A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62142124A (ja) * | 1983-04-08 | 1987-06-25 | Kureha Chem Ind Co Ltd | ヒト免疫グロブリン結合抗腫瘍剤 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01257331A (ja) * | 1987-12-10 | 1989-10-13 | Fuji Electric Co Ltd | マイクロ波整合装置とマイクロ波整合方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4962194A (enrdf_load_stackoverflow) * | 1972-05-10 | 1974-06-17 | ||
| JPS5161640A (en) * | 1974-09-20 | 1976-05-28 | Searle & Co | Koshuyozaino seizoho |
| JPS51144723A (en) * | 1975-05-27 | 1976-12-13 | Yeda Res & Dev | Antiitumor agent |
-
1979
- 1979-11-02 JP JP14215379A patent/JPS5665829A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4962194A (enrdf_load_stackoverflow) * | 1972-05-10 | 1974-06-17 | ||
| JPS5161640A (en) * | 1974-09-20 | 1976-05-28 | Searle & Co | Koshuyozaino seizoho |
| JPS51144723A (en) * | 1975-05-27 | 1976-12-13 | Yeda Res & Dev | Antiitumor agent |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62142124A (ja) * | 1983-04-08 | 1987-06-25 | Kureha Chem Ind Co Ltd | ヒト免疫グロブリン結合抗腫瘍剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6256137B2 (enrdf_load_stackoverflow) | 1987-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8223795A0 (it) | Gamma), relativi veicoli di polipeptidi contenenti la sequenza espressione, loro procedimento di degli amminoacidi dell'interferone preparazione, composizioni umano immune (interferone umano farmaceutiche contenenti tali polipeptidi. | |
| DK0458878T3 (da) | Nyt monoklonalt antistof mod et nyt antigen, der er associeret med humane tumorer | |
| SG96535A1 (en) | Pharmaceutical composition for the treatment or prevention of a malignant tumor | |
| RU92016463A (ru) | Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе | |
| AU3125289A (en) | Monoclonal antibodies directed against human tumor necrosis factor - receptor | |
| EP0261224A4 (en) | SYNTHETIC HTLV III PEPTIDE COMPOSITIONS AND THEIR USE. | |
| CA2098021A1 (en) | Composition Used as a Therapeutic Agent Against Chronic Viral Hepatic Diseases | |
| EP0147283A3 (en) | Immunomodulating medicine based on fe fragments of human igg | |
| CA2000913A1 (en) | Family of high affinity antibodies for cancer treatment | |
| Andrew et al. | Secretion of a macrophage‐activating factor distinct from interferon‐γ by human T cell clones | |
| EP0674661A4 (en) | TITRATION AND TREATMENT FOR DEMYELINIZING DISEASES SUCH AS MULTIPLE SCLEROSIS. | |
| IT8319160A0 (it) | Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi. | |
| GR852541B (enrdf_load_stackoverflow) | ||
| JPS5665829A (en) | Antitumor agent | |
| JPS5665828A (en) | Antitumor agent | |
| IL79260A (en) | Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficiencies | |
| JPS5592325A (en) | Antitumor agent and its preparation | |
| CA1017675A (en) | Use of l-prolyl l-leucyl glycine amide to treat parkinson's disease | |
| CA2308007A1 (en) | Enhancer for antibody to lymphocytic tumors | |
| FR2555755B1 (fr) | Procede de dosage des immunoglobulines humaines qui sont specifiques d'antigenes cancereux humains et application de ce procede dans le serodiagnostic de maladies tumorales primitives | |
| PH30662A (en) | Monoclonal antibodies against ifn-omega processes for preparing them and their use in the purification and detection of ifn-omega | |
| CA2002218A1 (en) | Neoglycoproteins, the preparation and use thereof | |
| IT1233005B (it) | Anticorpo umano monoclonale, composizione terapeutica che lo contiene linea cellulare capace di produrre l'anticorpo, procedimento per la sua produzione | |
| RU94045008A (ru) | Способ преодоления гематоэнцефалического барьера | |
| AU7275891A (en) | Synthetic peptides which contain sequences from factor viia, and the use thereof |